Recent Articles

Funding to support continuity of Zero Ch...

A 20-year record of fast-tracking treatm...

New drug yields extraordinary results in...

NHMRC grants reward researchers with bri...

Professor Maria Kavallaris awarded the W...

The bittersweet story of childhood leuka...

Australian nanomedicine research a ‘mi...

Exciting new research boosted by Cancer ...

Genome sequencing provides new path to m...

‘Moving the dial’ on treatment for c...

New DNA-based test on the horizon for ch...

Fast-tracking new treatments into clinic...

Join us this Childhood Cancer Awareness ...

Honours scholarship applications now ope...

Understanding high-risk leukaemia and ho...

New drug combination found to be effecti...

Targeting stem cells: the path to curing...

Science spotlight: Minimal Residual Dise...

Diary of a Researcher

International research collaboration rev...

New therapy shows ‘dramatic’ effect ...

Awareness Wednesday: Immunotherapy

Australian researchers find chink in the...

Anticancer Drug CBL0137 Highly Effective...

Therapy Developed For Alzheimers Could H...

New research paves the way for safer leu...

Science Spotlight: Leukaemia Stem Cells

Meet new Team Leader, Dr Charles de Bock

Fundamental mechanism behind chemotherap...

New Drug OBI-3424 An ‘Orphan Drug’ T...

A global effort to improve childhood can...

The past, present and future for young A...

My Daughter's Cancer Journey

How specific DNA ‘microdeletions’ he...

We made great strides with childhood leu...

Potential Leukaemia Drug Excites Interna...

Resistance is Futile: The MRP1 Story

Awareness Wednesday: Testing our results

Sights set on an aggressive childhood le...

New leukaemia subtype found by DNA test

Facts & figures draw a picture of childh...

Glowing report: firefly gene shows hidde...

An Aussie anti-cancer drug success story

It’s our party: 40 years of research

Targeting high-risk leukaemia subtypes

Awareness Wednesday: Leukaemia
